Trade Mark Journal No.2026/018 1 May 2026
UK00004372214 13 April 2026 (5)

- Class 5
- Pharmaceutical preparations and substances for the treatment of dermatological, musculoskeletal, rheumatological, gastroenterological, inflammatory, and immune system related diseases and disorders.
AbbVie Inc.
Representative: Carpmaels & Ransford LLP